Barbara has been a member of Clew’s board of directors since 2018. She also serves on corporate boards of HicuityHealth, and CareConnectMD. She is Vice Chair of the Board of SolveME/CFS, and is a member of the MassGeneralBrigham Innovation Growth Board, the Health Policy and Management Executive Council of the Harvard T.H. Chan School of Public Health, and the STEMAdvantage Advisory Board.
In her prior career as a health care executive, and later as a venture capitalist, Ms. Lubash led and advised innovative healthcare technology and services organizations. She was a founder and Managing Director of Versant Ventures, and before that was a Venture Partner at Crosspoint Ventures. Prior corporate boards include CodeRyte (acq 3M), Cogent Healthcare (acq Sound Physicians), Redbrick Health (acq Virgin Pulse), Titan Health (acq USPI), and Vantage Oncology (acq McKesson). She was Board Chair of the California HealthCare Foundation where she earlier led the formation of the Foundation’s PRI Innovation Fund). Ms. Lubash held prior operating roles at PacifiCare (now United), PHCS (PPO), and Hewlett Packard. She received a BS from Tufts University, and a Master’s in Health Policy and Management from Harvard Chan School of Public Health.
